Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-069836
Filing Date
2014-11-19
Accepted
2014-11-19 17:18:29
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v394556_10q.htm 10-Q 316132
2 EXHIBIT 31.1 v394556_ex31-1.htm EX-31.1 9667
3 EXHIBIT 31.2 v394556_ex31-2.htm EX-31.2 9872
4 EXHIBIT 32.1 v394556_ex32-1.htm EX-32.1 5269
5 EXHIBIT 32.2 v394556_ex32-2.htm EX-32.2 5611
  Complete submission text file 0001144204-14-069836.txt   3998723

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ppch-20140930.xml EX-101.INS 490462
7 XBRL TAXONOMY EXTENSION SCHEMA ppch-20140930.xsd EX-101.SCH 42340
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ppch-20140930_cal.xml EX-101.CAL 33311
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ppch-20140930_def.xml EX-101.DEF 246943
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ppch-20140930_lab.xml EX-101.LAB 279055
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ppch-20140930_pre.xml EX-101.PRE 278511
Mailing Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124
Business Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124 61 3 9208 4128
Propanc Health Group Corp (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 141236623
SIC: 2834 Pharmaceutical Preparations